Primary small intestinal malignant tumors: Survival analysis of 48 postoperative patients

Journal of Clinical Gastroenterology

Volumn 42, Issue 2, 2008, Pages 167-173

  Cao, Jun ^a   Zuo, Yunxia ^a   Lv, Fangfang ^a   Chen, Zhiyu ^a   Li, Jin ^a  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Chemotherapy; Prognostic factors; Small intestinal tumor

Indexed keywords

FLUOROURACIL; IMATINIB; PLATINUM DERIVATIVE;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; ECHOGRAPHY; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; PALLIATIVE THERAPY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; SMALL INTESTINE TUMOR; SURVIVAL RATE;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; INTESTINAL NEOPLASMS; INTESTINE, SMALL; MALE; MIDDLE AGED; PLATINUM; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

EID: 38349194858     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000248014.78020.7a     Document Type: Article

References (27)

1. Chen CC, Neugut AI, Rotterdam H. Risk factors for adenocarcinomas and malignant carcinoids of the small intestine: preliminary findings. Cancer Epidemiol Biomarkers Prev. 1994;3:205-207.
2. Ciccarelli O, Welch JP, Kent GG. Primary malignant tumors of the small bowel. The Hartford Hospital experience, 1969-1983. Am J Surg. 1987;153:350-354.
3. Neugut AI, Marvin MR, Rella VA, et al. An overview of adenocarcinoma of the small intestine. Oncology (Williston Park). 1997;11:529-536; discussion 545, 549-550.
4. O'Riordan BG, Vilor M, Herrera L. Small bowel tumors: an overview. Dig Dis. 1996;14:245-257.
5. Dabaja BS, Suki D, Pro B, et al. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer. 2004;101:518-526.
6. Chow JS, Chen CC, Ahsan H, et al. A population-based study of the incidence of malignant small bowel tumours: SEER, 1973-1990. Int J Epidemiol. 1996;25:722-728.
7. Kummar S, Ciesielski TE, Fogarasi MC. Management of small bowel adenocarcinoma. Oncology (Williston Park). 2002;16:1364-1369; discussion 1370, 1372-1373.
8. Howe JR, Karnell LH, Scott-Conner C. Small bowel sarcoma: analysis of survival from the National Cancer Data Base. Ann Surg Oncol. 2001;8:496-508.
9. Severson RK, Schenk M, Gurney JG, et al. Increasing incidence of adenocarcinomas and carcinoid tumors of the small intestine in adults. Cancer Epidemiol Biomarkers Prev. 1996;5:81-84.
10. Martin RG. Malignant tumors of the small intestine. Surg Clin North Am. 1986;66:779-785.
11. Yang YS, Huang QY, Wang WF, et al. Primary jejunoileal neoplasmas: a review of 60 cases. World J Gastroenterol. 2003;9:862-864.
12. Kusumoto H, Takahashi I, Yoshida M, et al. Primary malignant tumors of the small intestine: analysis of 40 Japanese patients. J Surg Oncol. 1992;50:139-143.
13. Mussi C, Caprotti R, Scaini A, et al. Management of small bowel tumors: personal experience and new diagnostic tools. Int Surg. 2005;90:209-214.
14. Folvik G, Bjerke-Larssen T, Odegaard S, et al. Hydrosonography of the small intestine: comparison with radiologic barium study. Scand J Gastroenterol. 1999;34:1247-1252.
15. Patak MA, Mortele KJ, Ros PR. Multidetector row CT of the small bowel. Radiol Clin North Am. 2005;43:1063-1077.
16. Horton KM, Fishman EK. Multidetector-row computed tomography and 3-dimensional computed tomography imaging of small bowel neoplasms: current concept in diagnosis. J Comput Assist Tomogr. 2004;28:106-116.
17. Delvaux M, Gerard Gay. Capsule endoscopy in 2005: facts and perspectives. Best Pract Res Clin Gastroenterol. 2006;20:23-39.
18. Eliakim AR. Video capsule endoscopy of the small bowel (PillCam SB). Curr Opin Gastroenterol. 2006;22:124-127.
19. Ugurlu MM, Asoglu O, Potter DD, et al. Adenocarcinomas of the jejunum and ileum: a 25-year experience. J Gastrointest Surg. 2005;9:1182-1188.
20. Barnes G Jr, Romero L, Hess KR, et al. Primary adenocarcinoma of the duodenum: management and survival in 67 patients. Ann Surg Oncol. 1994;1:73-78.
21. Talamonti MS, Goetz LH, Rao S, et al. Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management. Arch Surg. 2002;137:564-570; discussion 570-571.
22. Fishman PN, Pond GR, Moore MJ, et al. Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases. Am J Clin Oncol. 2006;29:225-231.
23. Koh PK, Horsman JM, Radstone CR, et al. Localised extranodal non-Hodgkin's lymphoma of the gastrointestinal tract: Sheffield Lymphoma Group experience (1989-1998). Int J Oncol. 2001;18:743-748.
24. Gibson MK, Holcroft CA, Kvols LK, et al. Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma. Oncologist. 2005;10:132-137.
25. Locher C, Malka D, Boige V, et al. Combination chemotherapy in advanced small bowel adenocarcinoma. Oncology. 2005;69:290-294.
26. Crawley C, Ross P, Norman A, et al. The Royal Marsden experience of a small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil. Br J Cancer. 1998;78:508-510.
27. Polyzos A, Kouraklis G, Giannopoulos A, et al. Irinotecan as salvage chemotherapy for advanced small bowel adenocarcinoma: a series of three patients. J Chemother. 2003;15:503-506.